Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04261127

Validation of the RADIAL Algorithm for Diagnosis of Autosomal Recessive Cerebellar Ataxia

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
5 Years
Healthy volunteers
Accepted

Summary

RADIAL is an algorithm which has been developed following a review of the literature on 67 autosomal recessive cerebellar ataxias (ARCA) and personal clinical experience. Frequency and specificity of each feature were defined for each autosomal recessive cerebellar ataxia, and corresponding prediction scores were assigned. Clinical and paraclinical features of patients are entered into the algorithm, and a patient's total score for each ARCA is calculated, producing a ranking of possible diagnoses. Sensitivity and specificity of the algorithm were assessed by blinded analysis of a multinational cohort of 834 patients with molecularly confirmed autosomal recessive cerebellar ataxia. The performance of the algorithm was assessed versus a blinded panel of autosomal recessive cerebellar ataxia experts. The correct diagnosis was ranked within the top 3 highest-scoring diagnoses at a sensitivity and specificity of \>90% for 84% and 91% of the evaluated genes, respectively. Mean sensitivity and specificity of the top 3 highest-scoring diagnoses were 92% and 95%, respectively. Our aim is now to validate in a prospective cohort of ARCA, the performance of RADIAL to predict the correct genetic diagnosis.

Conditions

Interventions

TypeNameDescription
GENETICGenetic diagnosis (PMDA panel)Blood samples for DNA study
DIAGNOSTIC_TESTUse of RADIAL algorithmRADIAL card filling (contains clinical and biological data)

Timeline

Start date
2021-09-20
Primary completion
2029-09-01
Completion
2029-09-01
First posted
2020-02-07
Last updated
2025-08-27

Locations

8 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04261127. Inclusion in this directory is not an endorsement.